Swedish Orphan Biovitrum valuation
Valuation
The P/E ratio is 25.0. The average price target of 12 analysts is kr 506.50.
Data as of November 18, 2026
Swedish Orphan Biovitrum compared with similar companies
Swedish Orphan Biovitrum's P/E (trailing 12 months): 25.0, in line with the median of a group of 11 similar companies (25.0).
| Metric | Swedish Orphan Biovitrum | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 25.0 | 25.0 | 18.1 – 33.0 | Middle |
| Forward P/E | 30.4 | 18.2 | 15.7 – 21.8 | High |
| EV/EBITDA | 14.0 | 12.3 | 10.5 – 16.2 | Middle |
| Price/book | 3.62 | 2.87 | 2.05 – 4.10 | Middle |
| Price/sales | 5.15 | 3.04 | 2.20 – 3.72 | High |
| Gross margin | 78.2% | 66.2% | 53.4% – 77.1% | High |
| Operating margin | 30.9% | 19.1% | 15.5% – 23.9% | High |
| Net margin | 20.7% | 12.8% | 8.9% – 15.1% | High |
| ROE | 16.3% | 11.4% | 8.7% – 16.5% | Middle |
| Debt/equity | 0.36 | 0.36 | 0.26 – 0.60 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Swedish Orphan Biovitrum: valuation over time
Swedish Orphan Biovitrum P/E and dividend yield at each fiscal year end, 2016 to 2025.
| Fiscal year | Price at year end | Earnings per share | P/E |
|---|---|---|---|
| 2025 | kr 332.80 | kr 1.37 | 242.9 |
| 2024 | kr 317.40 | kr 11.24 | 28.2 |
| 2023 | kr 267.00 | kr 7.39 | 36.1 |
| 2022 | kr 206.03 | kr 8.84 | 23.3 |
| 2021 | kr 176.80 | kr 9.03 | 19.6 |
| 2020 | kr 158.65 | kr 10.90 | 14.6 |
| 2019 | kr 147.57 | kr 11.22 | 13.2 |
| 2018 | kr 184.35 | kr 8.93 | 20.6 |
| 2017 | kr 107.27 | kr 4.25 | 25.2 |
| 2016 | kr 101.92 | kr 2.98 | 34.2 |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- kr 164.54B
- Enterprise value
- kr 179.69B
- PEG
- 0.25
- EV/revenue
- 5.62
Profitability and growth
- ROA
- 8.1%
- ROIC
- 13.2%
- Revenue growth (year over year)
- 17.3%
Financial health
- Total cash
- kr 1.01B
- Total debt
- kr 16.15B
- Current ratio
- 0.99
- Quick ratio
- 0.65
- Altman Z-Score
- 3.25
- Piotroski F-Score
- 7.00
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- kr 506.50
- Median price target
- kr 515.00
- High price target
- kr 600.00
- Low price target
- kr 308.00
- Analysts with a price target
- 12
- Consensus
- Buy
- Forward EPS
- kr 15.55
- EPS estimate, current year
- kr 20.50
Shares and trading
- Beta
- 0.33
- Average volume
- 339.73K
- Shares outstanding
- 348M
- Float
- 346.85M
- Institutional ownership
- 70.2%
- Insider ownership
- 10.1%
